Blog - Page 2994 of 5458

FridayApr 20, 2012 8:29 am

Rosetta Genomics, Ltd. (ROSG) Receives European Patent for miR-34a Use in Preparing Pharmaceuticals to Treat p53-Negative Cancers

Rosetta Genomics announced today that it has received a grant from the European Patent Office for a patent claiming the use of miR-34a for the preparation of pharmaceuticals to treat p53-negative cancers. A core element of Rosetta Genomics’ microRNA technology in the development of p53-negative-related cancer therapeutics is covered in the issued claims. The patent is owned jointly with Yeda, a technology transfer company of the Weizmann Institute of Science in Rehovot, Israel. The p53 protein, a sequence-specific transcription factor, functions as a major tumor suppressor in mammals. One of the most frequent genetic alterations in human cancer is the…

ThursdayApr 19, 2012 3:58 pm

Rockwell Diamonds, Inc. (RDIAF) Issues Update on Mining Activities and Corporate Strategy

Rockwell Diamonds reported a strategic and operational update on the company’s recent mining activities. The company owns an interest in three producing diamond mines in South Africa. Rockwell Diamonds is ramping up production at the Tirisano mine and expects this mine to be operating at full capacity by the end of July 2012. The company recently approved an equipment upgrade at Tirisano that will enable the company to deal with production problems associated with wet ores. Rockwell Diamonds reported strong growth in carat production at the Saxendrift mine, with year-over-year production rising by 50%. The company attributed the gain to…

ThursdayApr 19, 2012 2:46 pm

Location Based Technologies, Inc. (LBAS) Forms Strategic Partnership with West Coast Customs

Location Based Technologies Inc. (LBT), designer and developer of locator devices, today announced it has entered into a strategic partnership with West Coast Customs® (WCC), a luxury automotive restyling center with franchise operations worldwide. PocketFinder GPS easily attaches to any powered vehicle and allows the user to accurately locate their vehicle, and those in it, at any time and from almost anywhere in the world. Per the agreement, PocketFinder Vehicle® GPS devices will be installed into the WCC’s custom automobiles. “LBT is proud to be chosen as West Coast Customs’ preferred in-vehicle GPS solution,” Dave Morse, CEO of LBT stated…

ThursdayApr 19, 2012 12:53 pm

SmallCapVoice: Marley Coffee (JAMN) And AVT, Inc. Join Together For New Branded Automated Retailing Solutions

Marley Coffee, a sustainably grown, ethically farmed and artisan roasted gourmet coffee, today announced a licensing partnership agreement with AVT, Inc. (Pink Sheets:AVTC), a leading developer of automated and self-service retailing systems, to create high-end Marley Coffee branded automated coffee vending and merchandising machines for retail locations around the world. Both companies are seeking to target college campuses, traditional retail locations, high-density traffic areas, theatres, hotels and traditional foodservice vendors. Two of the AVT-developed Marley Coffee-branded vending machines will be unveiled at the National Automatic Merchandising Association (NAMA) OneShow at the Venetian/Sands in Las Vegas, April 25-27, at AVT, Inc.’s…

ThursdayApr 19, 2012 12:46 pm

SmallCapVoice: Advanced Medical Isotope Corp. (ADMD) Adds Regional Customer

Advanced Medical Isotope has finalized a sole-source contract with Kennewick General Hospital of Kennewick, Washington for the supply of short-lived radioisotopes primarily used in Positron emission tomography (PET) as well as for other medical isotopes utilized for diagnostic imaging and for therapeutic applications. Positron emission tomography (PET) has rapidly become a preferred scanning technique in medical research. A PET scanner utilizes radiation emitted from a patient to develop three dimensional images that assist in diagnosis with greater clarity than Magnetic Resonance Imaging (MRI) alone, and with computed tomography (CT) provides exceptionally detailed images for various types of cancers, cardiac disease…

ThursdayApr 19, 2012 12:42 pm

FluoroPharma Medical (FPMI) In Summary

FluoroPharma Medical, a developer of imaging agents for use with positron emission tomography (PET) scanning, helps to make visible subtle biological processes occurring deep within the body. From its founding in 2003, with technology licensed from Massachusetts General Hospital, the company has been steadily developing important imaging drugs for diagnostic testing, including much needed PET tracers for use in the diagnosis of cardiac disease at the cellular and molecular level. Below are some of the key facts relating to FluoroPharma. Lead Products: • BFPET – Myocardial perfusion imaging • CardioPET – Cardiac viability assessment • VasoPET – Inflamed atherosclerotic plaque…

ThursdayApr 19, 2012 12:26 pm

Palatin Technologies, Inc. (PTN) Announces Start of Second Phase I Trial of Its Obesity Compound

Palatin Technologies is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and significant commercial potential. Obesity is also a focus of the company. Palatin Technologies reported today that a second Phase I clinical trial of AZD2820 has begun with the dosing of the first patient. The compound is administered under the skin and is a peptide melanocortin receptor partial agonist which is under development for treating obesity. The compound is a clinical candidate selected by European drug firm AstraZeneca (NYSE: AZN) from a collaborative research program with Palatin Technologies. AstraZeneca has…

ThursdayApr 19, 2012 12:25 pm

SPI Solar, Inc. (SOPW) Inks MOU with Taneo Fund to Build 23MW of Solar Projects across Greece

SPI Solar, a leading vertically integrated photovoltaic (PV) solar developer, today announced that it has entered into a memorandum of understanding (MOU) with two fund management companies to develop utility-scale solar energy facilities (SEF) across Greece. Thermi-Taneo Venture Capital Fund and AIMS-Taneo Fund are part of the New Economic Development Fund called the Taneo Fund, a Greek-state sponsored, privately funded and independently managed fund-of-funds focused on venture-capital investments in Greece and Europe. The MOU greatly enhances SPI’s opportunity to triple its development projects across Greece. “We are very pleased to have this agreement in place. It represents a significant opportunity…

ThursdayApr 19, 2012 12:06 pm

Shelron Group, Inc. (SRNG) Moves to Secure Six Key Licenses on Prime Gold Exploration Acreage in Northern Chile

NY-headquartered mineral E&D (emphasis on gold and copper) company Shelron Group, which is primarily focused on rigorously analyzing and identifying key acquisition targets in Africa/South America, announced today that its newly formed subsidiary, Serena Gold, LLC, has signed a binding memorandum of understanding to acquire prime territory in Northern Chile via six (1,800) gold exploration licenses. This cherry little patch of land has stunning geological analogs, with the nearest being the producing Carmen de Andacollo deposit, which saw some $40M in output in 2010 alone (27,700 oz Au and 34.8kt of Cu). The soon-to-be-acquired prospect is just over five miles…

ThursdayApr 19, 2012 8:55 am

NeuroMetrix, Inc. (NURO) Files 510(k) for Pain Therapy Device

Yesterday, medical device company NeuroMetrix announced that it has filed a 501(k), also known as a premarket notification, with the Food and Drug Administration for its SENSUS Pain Therapy device. SENSUS is a non-invasive transcutaneous electrical nerve stimulator that is used for pain management and relief. The system is designed to treat chronic intractable pain, such as that associated with diabetic neuropathy. Painful diabetic neuropathy affects as many as 10-20% of people with diabetes, and is a serious and disabling complication of diabetic peripheral neuropathy (DPN). The pain is typically managed pharmacologically; however, many patients remain undertreated. Recent evidence based…

Site Search

Company Search